Willis Towers Watson Public Limited Co’s filing revealed that its Pres.-Health, Wealth & Career Gebauer Julie Jarecke unloaded Company’s shares for reported $0.55 million on Mar 03 ’25. In the deal valued at $338.74 per share,1,616 shares were sold. As a result of this transaction, Gebauer Julie Jarecke now holds 72,793 shares worth roughly $22.39 million.
Then, Gebauer Julie Jarecke bought 1,616 shares, generating $547,318 in total proceeds.
Before that, Gebauer Julie Jarecke sold 3,384 shares. Willis Towers Watson Public Limited Co shares valued at $1,136,243 were divested by the Pres.-Health, Wealth & Career at a price of $335.77 per share. As a result of the transaction, Gebauer Julie Jarecke now holds 74,417 shares, worth roughly $22.89 million.
UBS upgraded its Willis Towers Watson Public Limited Co [WTW] rating to a Buy from a a Neutral in a research note published on March 18, 2025; the price target was increased to $395 from $344. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who increased its forecast for the stock in early January from “an In-line” to “an Outperform”. Jefferies also remained covering WTW and has increased its forecast on December 20, 2024 with a “Buy” recommendation from previously “Hold” rating. Raymond James revised its rating on December 05, 2024. It rated WTW as “a Strong buy” which previously was an “an Outperform”.
Price Performance Review of WTW
On Tuesday, Willis Towers Watson Public Limited Co [NASDAQ:WTW] saw its stock fall -0.56% to $307.55. Over the last five days, the stock has gained 1.65%. Willis Towers Watson Public Limited Co shares have fallen nearly -1.82% since the year began. Nevertheless, the stocks have risen 21.81% over the past one year. While a 52-week high of $344.14 was reached on 03/04/25, a 52-week low of $248.09 was recorded on 04/25/25. SMA at 50 days reached $324.59, while 200 days put it at $307.90.
Levels Of Support And Resistance For WTW Stock
The 24-hour chart illustrates a support level at 305.69, which if violated will result in even more drops to 303.83. On the upside, there is a resistance level at 309.97. A further resistance level may holdings at 312.39. The Relative Strength Index (RSI) on the 14-day chart is 42.42, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.50, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 60.78%. Stochastics %K at 44.64% indicates the stock is a holding.
The most recent change occurred on September 05, 2024 when Barclays began covering the stock and recommended ‘”an Underweight”‘ rating along with a $278 price target.
